A Phase II Study of BMS-354825 in Subjects with Accelerated Phase Chronic MyeloidLeukemia Resistant to or Intolerant of Imatinib MesylateRevised Protocol 01: Incorporates Amendment 03 and Administrative Letter dated 01-March-2005.Amendment 01 country specific version 1.0 dated 2005-03-14

Category Primary study
Registry of TrialsEU Clinical Trials Register
Year 2004
This article has no abstract
Epistemonikos ID: d391f5dd2ae55e3e1a9387b30565fe12eb3cd2f9
First added on: Apr 17, 2025